Category: Early phase
Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now
FDA Finalizes Project Optimus Guidance for Dosing and Expectations for First-in-Human Oncology Trials The past 18 months have been Read Now
Traditional Site Networks Are Broken Building Real Site Relationships to Facilitate the Success of Early Phase Oncology Trials Oncology clinical Read Now
Rapid First Person In Milestone Less than 2 months for an oncology drug and device development company A drug and Read Now